Biblio Discovery — Demo Discovery Service

3 results for "Rodolphe Garraffo"

Showing 1–3 · 0.27 seconds · RSS

  1. Journal Article Full text

    Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients

    Gaurav Kumar; Jacqueline Cottalorda-Dufayard; Rodolphe Garraffo et al.

    Cells, Vol. 11 No. 2 · 2022 · English · DOAJ Scopus

    Raltegravir (RLT) prevents the integration of HIV DNA in the nucleus, but published studies remain controversial, suggesting that it does not decrease proviral DNA. However, there are only a few studies focused on virus-targeted cells. We aimed our study on the impact of RLT inclusion on total…

  2. Journal Article Full text

    Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice

    Pierre Gantner; Firouze Bani-Sadr; Rodolphe Garraffo et al.

    PLOS ONE, Vol. 11 No. 10 · 2016 · English · PLOS Scopus

    Objectives: To assess immunovirological response, safety and pharmacokinetic of NRTI-sparing regimen dual therapy of atazanavir (ATV) and raltegravir (RAL) in maintenance strategy. Methods: A retrospective analysis was conducted on a cohort of HIV-infected adults followed in French centers…

    Also available at: DOAJ